跳至主要内容
临床试验/IRCT20210720051946N7
IRCT20210720051946N7招募中2 期

Evaluation the effect of adding Sevelamer to the standard treatment of aluminum phosphide poisoning patients, referred to Tehran's Luqman Hospital, a preliminary studyon mortalit

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Taking the oral form of aluminum phosphide
  • Referral to Luqman Hospital within 24 hours
  • The presence of symptoms consistent with poisoning
  • Positive silver nitrate test
  • Carbon monoxide measurement above 10 in non-smokers

排除标准

  • glomerular filtration rate less than 30
  • History of kidney failure
  • History of liver failure
  • History of acute myocardial infarction
  • History of congenital heart disease
  • History of heart failure during pregnancy and breastfeeding
  • Referral after 24 hours of taking rice tablets

研究者

相似试验